Drug intelligence / Profile preview

Qi Huang Tong Mi Soft Capsules

Development stage: Preclinical
Lead developer: China Shineway Pharmaceutical Group
Administration: Oral

Overview

Qi Huang Tong Mi Soft Capsules is a Traditional Chinese Medicine (TCM) patent medicine developed by Rongchang Pharmaceutical (Zibo) Co., Ltd. for the treatment of functional constipation. Formulated as a soft capsule, it is a multi-herb botanical product designed to improve bowel movements and alleviate symptoms associated with constipation. It is currently being evaluated in clinical trials in China, including a randomized study comparing its efficacy and safety to Ma Ren Run Chang Soft Capsules. As a TCM formulation, its therapeutic effect is derived from a combination of herbal extracts, though the specific biological targets and individual active chemical constituents are not publicly detailed in standard pharmacological databases.

Brand names: Qi Huang Tong Mi Soft Capsules
Other names: Qihuang Tongmi Soft Capsules

Targets

IL1B (Interleukin-1 beta)NOS3 (eNOS)MAPK14 (p38 mitogen-activated protein kinase alpha)JNK (Mitogen-activated protein kinase kinase kinase family)PIK3CA (Phosphoinositide 3-kinase alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Qi Huang Tong Mi Soft Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qi Huang Tong Mi Soft Capsules.

Explore the full profile